Medtronic Heart Valves Division

Form 483 issued October 26, 2020 · Santa Ana, California

Inspection
Oct 13 – Oct 26, 2020
Investigator
Kirtida Patel
Observations
2
Pages
7
FEI number
2025587

In short: On October 26, 2020, FDA issued a Form 483 with 2 observations to Medtronic Heart Valves Division in Santa Ana, California (FEI 2025587) after an inspection that ran Oct 13 – Oct 26, 2020. The investigator was Kirtida Patel. Most observations concern cAPA; the most-cited regulation is 21 CFR 820.198 (complaint files).

At a glance

2 of 2 observations on this 483 concern capa.

CAPA2

Most cited: 21 CFR 820.198(c) (1×) · 820.100(a) (1×)

What FDA observed

Preview: the opening words of each observation
  1. 01

    Complaints involving the possible failure of a device to meet any of its specifications were not…

  2. 02

    Procedures for corrective and preventive action have…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Medtronic Heart Valves Division?

FDA listed 2 observations on this Form 483, mostly about cAPA. The most-cited regulation is 21 CFR 820.198 (complaint files). The opening words of each observation are shown on this page.

Who inspected Medtronic Heart Valves Division?

Kirtida Patel is named on this Form 483, for the inspection of Oct 13 – Oct 26, 2020. Each investigator has a profile showing what they cite most.

When was Medtronic Heart Valves Division inspected by FDA?

The inspection ran Oct 13 – Oct 26, 2020, and the Form 483 is dated October 26, 2020.

How do I get the full Form 483 for Medtronic Heart Valves Division?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free